Gjertsen BT
ORCID: 0000-0001-9358-9704
· 1 paper in corpus
PurposeValproic acid (VPA) is suggested to be therapeutically beneficial in combination with interferon-alpha (IFNα) in various cancers. Therefore, we examined IFNα and VPA alone and in combinations in selected AML models, examining immune …